| Product Code: ETC12838697 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Suriname continues to rely on imported influenza medications, with key suppliers including Netherlands, India, Germany, Hong Kong, and Guyana in 2024. The market shows high concentration, as indicated by the HHI, with a steady CAGR of 2.76% from 2020 to 2024. Despite facing challenges, the sector experienced a growth rate of 2.35% in 2024. This data suggests a stable demand for influenza medications in Suriname, with potential opportunities for market expansion and diversification in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Influenza Medications Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Suriname Influenza Medications Market - Industry Life Cycle |
3.4 Suriname Influenza Medications Market - Porter's Five Forces |
3.5 Suriname Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Suriname Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Suriname Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Suriname Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of influenza vaccinations in Suriname |
4.2.2 Rising prevalence of influenza cases in Suriname |
4.2.3 Government initiatives to improve access to healthcare services, including influenza medications |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and resources in Suriname |
4.3.2 High cost of influenza medications in the market |
4.3.3 Lack of comprehensive vaccination programs in Suriname |
5 Suriname Influenza Medications Market Trends |
6 Suriname Influenza Medications Market, By Types |
6.1 Suriname Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Suriname Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Suriname Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Suriname Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Suriname Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Suriname Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Suriname Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Suriname Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Suriname Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Suriname Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Suriname Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Suriname Influenza Medications Market Import-Export Trade Statistics |
7.1 Suriname Influenza Medications Market Export to Major Countries |
7.2 Suriname Influenza Medications Market Imports from Major Countries |
8 Suriname Influenza Medications Market Key Performance Indicators |
8.1 Number of influenza vaccinations administered annually in Suriname |
8.2 Percentage of population covered by health insurance that includes coverage for influenza medications |
8.3 Rate of adherence to prescribed influenza medications in Suriname |
9 Suriname Influenza Medications Market - Opportunity Assessment |
9.1 Suriname Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Suriname Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Suriname Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Suriname Influenza Medications Market - Competitive Landscape |
10.1 Suriname Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Suriname Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here